Share on StockTwits

Enzymotec (NASDAQ:ENZY) reached a new 52-week low on Wednesday , ARN reports. The stock traded as low as $8.55 and last traded at $8.74, with a volume of 75,705 shares. The stock had previously closed at $9.05.

Several analysts have recently commented on the stock. Analysts at Jefferies Group cut their price target on shares of Enzymotec from $14.50 to $10.00 in a research note on Wednesday, August 6th. Analysts at Wells Fargo & Co. downgraded shares of Enzymotec from an “outperform” rating to a “market perform” rating in a research note on Wednesday, August 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the stock. Enzymotec currently has a consensus rating of “Hold” and an average price target of $20.00.

The stock has a 50-day moving average of $12.9 and a 200-day moving average of $18.50. The company has a market cap of $190.7 million and a price-to-earnings ratio of 26.70.

Enzymotec (NASDAQ:ENZY) last released its earnings data on Tuesday, August 5th. The company reported $0.02 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.10 by $0.08. The company had revenue of $11.50 million for the quarter, compared to the consensus estimate of $14.88 million. The company’s quarterly revenue was down 40.3% on a year-over-year basis. On average, analysts predict that Enzymotec will post $0.37 earnings per share for the current fiscal year.

Enzymotec Ltd. is engaged in manufacturing of ingredients and medical foods company. Its technologies, research, and clinical validation process enables the Company to develop differentiated solutions across a variety of products.

Receive News & Ratings for Enzymotec Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzymotec Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.